Medicinal Product Shortages - update - 28 April 2021

Notice type: Advisory

Date: 28/04/2021

The Health Products Regulatory Authority has been notified of a shortage of the following products:

• Azacitidine Mylan 25mg/ml Powder for Suspension for Injection – EU/1/20/1426/001
• Azarga 10mg/ml + 5mg/ml Eye Drop Suspension – EU/1/08/482/001
• Canesten HC 1% w/w & 1% w/w Cream – PA1040/040/002
• Caverject 10mcg Powder and Solvent for Solution for Injection – PA0822/115/002
• Clexane 40,000IU/0.4ml Solution for Injection in Prefilled Syringe – PA0540/097/005
• Cyklokapron 500mg Tablet – PA2010/055/001
• Diclac 50mg Gastro-resistant Tablet – PA0711/009/008
• Lercanidipine Clonmel 10mg Film Coated Tablet – PA0126/187/001
• Lercanidipine Clonmel 20mg Film Coated Tablet – PA0126/187/002
• Parlodel 2.5mg Tablet – PA2010/042/001
• Primovist 0.25mmol/ml Solution for Injection in Prefilled Syringe – PA1410/021/001
• Rifinah 300mg/150mg Tablet – PA0540/068/002

The following shortages have been resolved and supply has resumed to the Irish market:

• Anastrozole Teva 1mg Film Coated Tablet – PA0749/028/001
• Champix 0.5mg Tablet – EU/1/06/360/001
• Flutiform 50mcg/5mcg per metered dose Pressurised Inhalation Suspension – PA1688/013/001
• Lignospan Special 20mg/12.5mg 2.2ml Solution for Injection – PA0196/013/001
• Lignospan Special 20mg/12.5mg 1.8ml Solution for Injection – PA0196/013/002
• Losartan 50mg Film Coated Tablet – PA0749/090/003
• Scandonest 3% w/v Solution for Injection – PA0196/015/001
• Tracrium 10mg/ml Solution for Injection or Infusion (250mg/2ml vial only) – PA1691/029/002
• Xylonor 150mg/g + 1.5mg/g Oromucosal Spray – PA0196/014/001
• Xylonor 50mg/g + 1.5mg/g Gingival Gel – PA0196/014/002